NIRS Imaging for Ulcers
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if Near Infrared Spectroscopy (NIRS) can predict the healing of chronic ulcers (long-lasting open sores) on the lower legs and other areas. Participants will receive either standard care or standard care plus NIRS imaging, which uses special light to examine the ulcers. Individuals with long-lasting leg ulcers or other non-healing sores receiving treatment at Christus Wound Care and Hyperbaric Medicine Departments are suitable candidates for this study. As an unphased trial, this study allows participants to contribute to innovative research that could enhance future ulcer treatments.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that NIRS imaging is safe for use in chronic ulcer assessment?
Research has shown that NIRS imaging can predict ulcer healing by assessing blood oxygen levels. This non-invasive technology does not involve entering the body, often making it safer. Studies indicate that patients generally tolerate NIRS imaging well. No major reports of negative effects have emerged from its use, suggesting that NIRS imaging is generally safe for patients with ulcers.12345
Why are researchers excited about this trial?
Researchers are excited about using NIRS imaging for ulcers because it offers a non-invasive way to assess tissue health, potentially allowing for earlier and more accurate detection of problem areas. Unlike standard care options, which often rely on visual inspection and subjective assessment, NIRS (Near-Infrared Spectroscopy) provides objective data by measuring oxygen levels in the tissue. This innovative approach could lead to more personalized treatment plans and better outcomes for patients, as it helps clinicians target the most at-risk areas with precision.
What evidence suggests that NIRS imaging is effective for chronic ulcers?
Research has shown that NIRS imaging, which participants in this trial may receive, can predict the healing of venous leg ulcers and diabetic foot ulcers by monitoring changes in blood oxygen levels. This non-invasive imaging technique does not involve any cutting or surgery. It measures tissue oxygen levels to assess the wound's healing potential. Studies have demonstrated that NIRS imaging provides reliable information on wound healing. Overall, NIRS imaging aids doctors in understanding and predicting the healing process of chronic ulcers.12678
Who Is on the Research Team?
Marcus L Gitterle, MD
Principal Investigator
CHRISTUS Santa Rosa Hospital Wound Care and Hyperbaric Center - San Antonio, Westover Hills, San Marcos and New Braunfels
Are You a Good Fit for This Trial?
This trial is for current or incoming patients at Christus Wound Care and Hyperbaric Medicine Departments with lower extremity ulcers or other chronic non-healing ulcers. It's open to those treated between July and December 2024, regardless of the cause of their wounds.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive standard care with or without NIRS imaging for chronic ulcers
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- NIRS imaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kent Imaging Inc
Lead Sponsor
WoundCentrics LLC
Collaborator